Essential Hypertension

Use the ACC/AHA office classification at the decision point: stage 1 hypertension is SBP 130-139 mm Hg or DBP 80-89 mm Hg, and stage 2 hypertension is BP at least 140/90 mm Hg. This lower diagnostic threshold differs from European guidance, which retains 140/90 mm Hg for diagnosis. acpjournals+2acpjournalsThe ACC/AHA 2017 Hypertension GuidelinesACC2023 ESH Hypertension Guideline Update: Bringing Us ...ACCHigh blood pressure redefined for first time in 14 years: 130 is the new high - American College of Cardiology

In an untreated adult with office SBP greater than 130 but less than 160 mm Hg or DBP greater than 80 but less than 100 mm Hg, obtain daytime ABPM or HBPM to screen for white-coat hypertension before diagnosing hypertension. This is particularly consequential when drug treatment would otherwise be deferred or initiated solely from office readings. AHA JournalsAHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...

Classify discordant measurements explicitly. White-coat hypertension is elevated office BP with lower ambulatory or home BP; masked hypertension is the inverse pattern. Do not regard HBPM and ABPM as interchangeable when a decision to withhold or avoid intensifying medication hinges on the result: their diagnostic overlap for white-coat hypertension is only 60%-70%, and ABPM has stronger cardiovascular risk-prediction evidence. AHA Journals+1AHA JournalsPrognosis of White-Coat and Masked Hypertension | HypertensionAHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...

Obtain HbA1c, electrolytes, creatinine with estimated glomerular filtration rate, total cholesterol, and HDL cholesterol; examine the fundi for hypertensive retinopathy; and obtain a 12-lead ECG. These tests identify kidney dysfunction, diabetes, lipid risk, retinal target-organ injury, and cardiac abnormalities that alter global cardiovascular-risk assessment and treatment planning. nice org uknice org ukHypertension in adults: diagnosis and management

For adults with established cardiovascular disease, begin antihypertensive pharmacotherapy at BP at least 130/80 mm Hg. The same medication threshold applies to patients with an estimated 10-year ASCVD risk greater than 10%; patients with SBP at least 140 mm Hg or DBP at least 90 mm Hg should receive drug treatment regardless of calculated cardiovascular risk. ACCACC2023 ESH Hypertension Guideline Update: Bringing Us ...

Use the 130/80 mm Hg ACC/AHA threshold as the U.S. framework, but recognize that classification and treatment thresholds are not internationally uniform. European guidance uses a diagnostic threshold above 140/90 mm Hg, while both guideline approaches endorse drug treatment for established cardiovascular disease at BP at least 130/80 mm Hg and for BP at least 140/90 mm Hg independent of calculated risk. ACCACC2023 ESH Hypertension Guideline Update: Bringing Us ...

For most adults in the ACC/AHA framework, the treatment target is BP below 130/80 mm Hg. The rationale for lower targets includes trial evidence that intensive BP lowering reduces cardiovascular risk, although treatment intensity must be individualized when adverse effects, comorbidity, or measurement uncertainty make further escalation unsafe or uninformative. JAMA+1JAMABlood Pressure Lowering and Risk of Mortality in Chronic ...ACCNew in Clinical Guidance | High Blood Pressure Focus ...

Use HBPM or ABPM to assess response after treatment changes rather than relying exclusively on office BP. Out-of-office monitoring both improves recognition of uncontrolled BP and identifies white-coat uncontrolled hypertension, in which medication escalation based on office BP alone can expose patients to unnecessary chronic treatment. Nature+3NatureOut-of-office blood pressure monitoring in defining and confirming true resistant hypertension | Hypertension ResearchAHA JournalsPredicting Out-of-Office Blood Pressure in the Clinic (PROOF-BP) | HypertensionAHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...ScienceDirectWhite Coat Hypertension - an overview | ScienceDirect Topics

Maintain lifestyle intervention throughout treatment. Recommended targets include dietary improvement, regular exercise, reduction of excessive alcohol intake, weight reduction when indicated, smoking cessation, and avoidance of over-the-counter or other agents that may contribute to poor BP control. nice org uk+2nice org ukHypertension in adultsnice org ukHypertension in adults: diagnosis and managementESCWhat is new in resistant hypertension?

Define apparent resistant hypertension as BP above goal despite at least three antihypertensive agents of different mechanisms at maximally tolerated doses, preferably including an ACE inhibitor or ARB, a long-acting dihydropyridine calcium-channel blocker, and a diuretic; controlled BP requiring at least four medications also meets the resistant-hypertension definition. ccjmccjmResistant hypertension: A stepwise approach | Cleveland Clinic Journal of medicine Before assigning true resistance, exclude poor measurement technique, nonadherence, and white-coat effect. ccjm+2ccjmResistant hypertension: A stepwise approach | Cleveland Clinic Journal of medicineESCWhat is new in resistant hypertension?ESCCombination therapy at the start of hypertension treatment: pros and cons

Confirm persistent out-of-office elevation with ABPM or HBPM after adherence and lifestyle factors have been assessed. In an apparent-resistant cohort evaluated with office and ambulatory readings, 9% had white-coat uncontrolled hypertension and 15% had masked uncontrolled hypertension, illustrating why office BP alone should not trigger serial drug escalation. NatureNatureOut-of-office blood pressure monitoring in defining and confirming true resistant hypertension | Hypertension Research

Evaluate confirmed resistant hypertension for secondary causes after pseudo-resistance is removed. The practical sequence is to verify the prescribed regimen and maximal tolerated doses, assess adherence, review sodium intake and precipitating medications or acute conditions, confirm out-of-office BP, then pursue a directed secondary-hypertension evaluation. ccjm+2ccjmResistant hypertension: A stepwise approach | Cleveland Clinic Journal of medicineESCWhat is new in resistant hypertension?ESCCombination therapy at the start of hypertension treatment: pros and cons

Severe hypertension with overt target-organ damage is a hypertensive emergency and requires emergency evaluation, intravenous titratable BP reduction, and hospital-level monitoring. Rapid normalization is unsafe in chronic hypertension because autoregulatory adaptation can make abrupt lowering cause tissue hypoperfusion; an incremental reduction strategy is required. ScienceDirectScienceDirectHypertensive Urgency - an overview

Escalate confirmed resistant hypertension for directed secondary-cause evaluation when BP remains above goal after adherence verification, out-of-office confirmation, and optimized multidrug therapy. Resistant hypertension carries increased risk of cardiovascular disease, stroke, kidney failure, and death, so repeated office-only medication changes are not an adequate endpoint. ccjmccjmResistant hypertension: A stepwise approach | Cleveland Clinic Journal of medicine

Use the initial hypertension evaluation to identify renal impairment, retinopathy, ECG abnormalities, diabetes, and dyslipidemia, then incorporate these findings into the urgency of follow-up and global cardiovascular-risk reduction. nice org uknice org ukHypertension in adults: diagnosis and management